Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Rubbert-Roth, Andrea, Enejosa, Jeffrey, Pangan, Aileen L, Haraoui, Boulos, Rischmueller, Maureen, Khan, Nasser, Zhang, Ying, Martin, Naomi, Xavier, Ricardo M
Published in The New England journal of medicine (15.10.2020)
Published in The New England journal of medicine (15.10.2020)
Get full text
Journal Article
ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: A Randomized, Double-Blind Study
Genovese, Mark C, Weinblatt, Michael E, Aelion, Jacob A, Mansikka, Heikki T, Peloso, Paul M, Chen, Kun, Li, Yihan, Othman, Ahmed A, Khatri, Amit, Khan, Nasser S, Padley, Robert J
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.11.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.11.2018)
Get full text
Journal Article
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Fleischmann, Roy, Mysler, Eduardo, Bessette, Louis, Peterfy, Charles G, Durez, Patrick, Tanaka, Yoshiya, Swierkot, Jerzy, Khan, Nasser, Bu, Xianwei, Li, Yihan, Song, In-Ho
Published in Rheumatic & musculoskeletal diseases open (01.02.2022)
Published in Rheumatic & musculoskeletal diseases open (01.02.2022)
Get full text
Journal Article
Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial
van Vollenhoven, Ronald, Strand, Vibeke, Takeuchi, Tsutomu, Chávez, Nilmo, Walter, Pablo Mannucci, Singhal, Atul, Swierkot, Jerzy, Khan, Nasser, Bu, Xianwei, Li, Yihan, Penn, Sara K, Camp, Heidi S, Aelion, Jacob
Published in Arthritis research & therapy (29.07.2024)
Published in Arthritis research & therapy (29.07.2024)
Get full text
Journal Article
An international survey of the structure and process of care for traumatic spinal cord injury in acute and rehabilitation facilities: lessons learned from a pilot study
Abedi, Aidin, Biering-Sørensen, Fin, Chhabra, Harvinder S, D'Andréa Greve, Julia Maria, Khan, Nasser M, Koskinen, Eerika, Kwan, Kenny Yat Hong, Liu, Nan, Middleton, James W, Moslavac, Sasa, Rahimi-Movaghar, Vafa, O'Connell, Colleen, Previnaire, Jean G, Patel, Alpesh, Scivoletto, Giorgio, Sharwood, Lisa N, Townson, Andrea, Urquhart, Susan, Vainionpää, Aki, Zaman, Atiq Uz, Noonan, Vanessa K, Cheng, Christiana L
Published in BMC health services research (21.12.2022)
Published in BMC health services research (21.12.2022)
Get full text
Journal Article
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Charles-Schoeman, Christina, Choy, Ernest, McInnes, Iain B, Mysler, Eduardo, Nash, Peter, Yamaoka, Kunihiro, Lippe, Ralph, Khan, Nasser, Shmagel, Anna K, Palac, Hannah, Suboticki, Jessica, Curtis, Jeffrey R
Published in Rheumatic & musculoskeletal diseases open (01.11.2023)
Published in Rheumatic & musculoskeletal diseases open (01.11.2023)
Get full text
Journal Article
ABT‐122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin‐17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate
Genovese, Mark C., Weinblatt, Michael E., Aelion, Jacob A., Mansikka, Heikki T., Peloso, Paul M., Chen, Kun, Li, Yihan, Othman, Ahmed A., Khatri, Amit, Khan, Nasser S., Padley, Robert J.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.11.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.11.2018)
Get full text
Journal Article
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study
Fleischmann, Roy, Meerwein, Sebastian, Charles-Schoeman, Christina, Combe, Bernard, Hall, Stephen, Khan, Nasser, Carter, Kyle M, Camp, Heidi S, Rubbert-Roth, Andrea
Published in Rheumatic & musculoskeletal diseases open (25.07.2024)
Published in Rheumatic & musculoskeletal diseases open (25.07.2024)
Get full text
Journal Article
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study
Rubbert-Roth, Andrea, Kato, Koji, Haraoui, Boulos, Rischmueller, Maureen, Liu, Yanxi, Khan, Nasser, Camp, Heidi S., Xavier, Ricardo M.
Published in Rheumatology and therapy. (01.10.2024)
Published in Rheumatology and therapy. (01.10.2024)
Get full text
Journal Article
Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE
Fleischmann, Roy, Blanco, Ricardo, Van den Bosch, Filip, Bessette, Louis, Song, Yanna, Penn, Sara K., McDearmon-Blondell, Erin, Khan, Nasser, Chan, Kelly, Mysler, Eduardo
Published in Rheumatology and therapy. (01.06.2024)
Published in Rheumatology and therapy. (01.06.2024)
Get full text
Journal Article
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study
Fleischmann, Roy, Swierkot, Jerzy, Penn, Sara K, Durez, Patrick, Bessette, Louis, Bu, Xianwei, Khan, Nasser, Li, Yihan, Peterfy, Charles G, Tanaka, Yoshiya, Mysler, Eduardo
Published in Rheumatic & musculoskeletal diseases open (28.05.2024)
Published in Rheumatic & musculoskeletal diseases open (28.05.2024)
Get full text
Journal Article
Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
Kivitz, Alan, Wells, Alvin F., Vargas, Juan I., Baraf, Herbert S. B., Rischmueller, Maureen, Klaff, Justin, Khan, Nasser, Li, Yihan, Carter, Kyle, Friedman, Alan, Durez, Patrick
Published in Rheumatology and therapy. (01.08.2023)
Published in Rheumatology and therapy. (01.08.2023)
Get full text
Journal Article
Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants
Parekh, Sameer, Zoulim, Fabien, Ahn, Sang Hoon, Tsai, Adrienne, Li, Jisu, Kawai, Shigenobu, Khan, Nasser, Trépo, Christian, Wands, Jack, Tong, Shuping
Published in Journal of Virology (01.06.2003)
Published in Journal of Virology (01.06.2003)
Get full text
Journal Article
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years
Charles-Schoeman, Christina, Giles, Jon T., Lane, Nancy E., Choy, Ernest, Furst, Daniel E., Vencovský, Jiří, Wilson, Anthony G., Burmester, Gerd R., Coombs, Derek, Penn, Sara K., Khan, Nasser, Yee, Jillian B., Rahawi, Kassim, McInnes, Iain B.
Published in Rheumatology and therapy. (01.02.2024)
Published in Rheumatology and therapy. (01.02.2024)
Get full text
Journal Article
Modulation of Hepatitis B Virus Secretion by Naturally Occurring Mutations in the S Gene
KHAN, Nasser, GUARNIERI, Michael, SANG HOON AHN, JISU LI, YONGHONG ZHOU, GENIE BANG, KIM, Kyun-Hwan, WANDS, Jack R, SHUPING TONG
Published in Journal of Virology (01.04.2004)
Published in Journal of Virology (01.04.2004)
Get full text
Journal Article
The setting up and running of a cross-county out-of-hours gastrointestinal bleed service: a possible blueprint for the future
Shokouhi, Bahman N, Khan, Mohammad, Carter, Martyn J, Khan, Nasser Q, Mills, Philip, Morris, Danielle, Rowlands, David E, Samsheer, Kote, Sargeant, Ian R, McIntyre, Peter B, Greenfield, Simon M
Published in Frontline gastroenterology (01.07.2013)
Published in Frontline gastroenterology (01.07.2013)
Get full text
Journal Article
Book Review
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
Cohen, Stanley B, van Vollenhoven, Ronald F, Winthrop, Kevin L, Zerbini, Cristiano A F, Tanaka, Yoshiya, Bessette, Louis, Zhang, Ying, Khan, Nasser, Hendrickson, Barbara, Enejosa, Jeffrey V, Burmester, Gerd R
Published in Annals of the rheumatic diseases (01.03.2021)
Published in Annals of the rheumatic diseases (01.03.2021)
Get full text
Journal Article
A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy
Kremer, Joel M., Emery, Paul, Camp, Heidi S., Friedman, Alan, Wang, Li, Othman, Ahmed A., Khan, Nasser, Pangan, Aileen L., Jungerwirth, Steven, Keystone, Edward C.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2016)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2016)
Get full text
Journal Article
Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Genovese, Mark C., Smolen, Josef S., Weinblatt, Michael E., Burmester, Gerd R., Meerwein, Sebastian, Camp, Heidi S., Wang, Li, Othman, Ahmed A., Khan, Nasser, Pangan, Aileen L., Jungerwirth, Steven
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2016)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2016)
Get full text
Journal Article